Ben Hall to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Ben Hall has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.027
-
Lung tumors with distinct p53 mutations respond similarly to p53 targeted therapy but exhibit genotype-specific statin sensitivity. Genes Dev. 2017 07 01; 31(13):1339-1353.
Score: 0.027
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.